Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Velázquez-Pérez, Luis; Rodríguez-Chanfrau, Jorge; García-Rodríguez, Julio Cesar; Sánchez-Cruz, Gilberto; Aguilera-Rodríguez, Raúl; Rodríguez-Labrada, Roberto; Rodríguez-Díaz, Julio Cesar; Canales-Ochoa, Nalia; Almaguer Gotay, Dennis; Almaguer Mederos, Luis E; Laffita Mesa, José M; Porto-Verdecia, Marlene; González Triana, Consuelo; Rodríguez Pupo, Noemí; Hidalgo Batista, Idania; López-Hernandez, Orestes D; Díaz Polanco, Iverlis; Jayme Novas, Arelis.
Nat. hum ; 36(10)oct. 2011. tab, graf
Artículo en Inglés | CUMED | ID: cum-60088

Documentos relacionados

  1. Spinocerebellar Ataxia Type 10 with Atypical Clinical Manifestation in Han Chinese.
  2. [Abnormalities in signal transduction of Purkinje cells in spinocerebellar ataxias: a review].
  3. Genetic Epidemiology and Clinical Characteristics of Patients with Spinocerebellar Ataxias in an Unexplored Brazilian State, Using Strategies for Resource-Limited Settings.
  4. The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications.
  5. Perceptual and Acoustic Analysis of Speech in Spinocerebellar ataxia Type 1.
  6. New Case of Spinocerebellar Ataxia, Autosomal Recessive 4, Due to <i>VPS13D</i> Variants.
  7. Cognitive, Emotional, and Other Non-motor Symptoms of Spinocerebellar Ataxias.
  8. Fast and reliable detection of repeat expansions in spinocerebellar ataxia using exomes.
  9. Early-onset familial essential tremor is associated with nucleotide expansions of spinocerebellar ataxia in China.
  10. Expanding the Landscape of Spinocerebellar Ataxia Type 5.